Addendum to the note for guidance on antiarrhythmics on atrial fibrillation and atrial flutter

Current effective version

PDF iconAdopted guideline

Reference numberCHMP/EWP/213056/2010
Effective from01/02/2011
KeywordsAtrial fibrillation, rhythm control, rate control, cardioversion
DescriptionThis document is an addendum to the note for guidance on antiarrhythmics. It provides guidance for the evaluation of new medicinal products or drugs used in the antiarrhythmic treatment of atrial fibrillation.

Document history

First version

Current version

PDF iconAdopted guideline


PDF iconDraft guideline


PDF iconConcept paper

In operation: 01/12/2011–present


Published: 24/07/2008


Published: 21/09/2006

Related content


How useful was this page?

Add your rating